Sucampo buying Swiss and Japanese patent firms for $28.1M cash
This article was originally published in Scrip
Executive Summary
Sucampo Pharmaceuticals is acquiring Swiss patent-holding firm Sucampo and its Japanese patent maintenance subsidiary for $28.1 million in cash plus a seven-year $51.9 million subordinated unsecured promissory note.